IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2025-01-01 to 2025-03-31

Swipe to see the full flow
IDEXX LABORATORIES INC /DE cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $237,962,000.00Net income → Operating adjustments reconciliation: $4,715,000.00Depreciation and amortization → Operating adjustments reconciliation: $34,063,000.00Share-based compensation expense → Operating adjustments reconciliation: $14,615,000.00Deferred income taxes → Operating adjustments reconciliation: $3,948,000.00Provision for credit losses → Operating adjustments reconciliation: $2,890,000.00Inventories → Operating adjustments reconciliation: $2,163,000.00Deferred revenue → Operating adjustments reconciliation: $838,000.00Other → Operating adjustments reconciliation: $456,000.00Operating adjustments reconciliation → Accounts receivable: $45,240,000.00Operating adjustments reconciliation → Other assets and liabilities: $10,325,000.00Operating adjustments reconciliation → Accounts payable: $8,123,000.00Proceeds from net investment hedges → investing reconciliation: $416,000.00investing reconciliation → Purchases of property and equipment: $30,026,000.00Net cash used in financing activities → financing reconciliation: $330,321,000.00Borrowings under credit facility, net → financing reconciliation: $69,500,000.00Proceeds from exercises of stock options and employee stock purchase plans → financing reconciliation: $7,193,000.00financing reconciliation → Repurchases of common stock: $400,890,000.00financing reconciliation → Shares withheld for statutory tax withholding payments on restricted stock: $6,124,000.00Net cash used in investing activities → investing reconciliation: $29,610,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $288,266,000.00Net cash from operating activities → Cash sources and uses: $237,962,000.00Cash sources and uses → Exchange-rate effect: $2,327,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $163,970,000.00Cash sources and uses → Net cash used in investing activities: $29,610,000.00Cash sources and uses → Net cash used in financing activities: $330,321,000.00Net income: $242,677,000.00Net income+$242.68 MDepreciation and amortization: $34,063,000.00Depreciation & amortization+$34.06 MProvision for credit losses: $2,890,000.00Loan & lease loss provision+$2.89 MDeferred income taxes: $3,948,000.00Deferred taxes & credits+$3.95 MShare-based compensation expense: $14,615,000.00Stock-based compensation+$14.62 MOther: $456,000.00Other operating, net+$456.00 KAccounts receivable: -$45,240,000.00Accounts receivable−$45.24 MInventories: $2,163,000.00Inventories+$2.16 MAccounts payable: -$8,123,000.00Accounts payable−$8.12 MDeferred revenue: $838,000.00Deferred revenue+$838.00 KOther assets and liabilities: -$10,325,000.00Other working capital, net−$10.33 MImpairment charge: $0.00Net cash from operating activities: $237,962,000.00Operating cash+$237.96 MOperating adjustments reconciliation: $63,688,000.00Shares withheld for statutory tax withholding payments on restricted stock: -$6,124,000.00Stock-award tax withholding−$6.12 MBorrowings under credit facility, net: $69,500,000.00Credit lines, net+$69.50 MProceeds from exercises of stock options and employee stock purchase plans: $7,193,000.00Employee stock plans & options+$7.19 MRepurchases of common stock: -$400,890,000.00Common stock repurchases−$400.89 MNet cash used in financing activities: -$330,321,000.00. Cash required to fund net payments.Financing cash−$330.32 Mfinancing reconciliation: $407,014,000.00Purchases of property and equipment: -$30,026,000.00PP&E purchases−$30.03 MAcquisition of a business: $0.00Proceeds from net investment hedges: $416,000.00Investing hedge proceeds+$416.00 KNet cash used in investing activities: -$29,610,000.00. Cash required to fund net payments.Investing cash−$29.61 Minvesting reconciliation: $30,026,000.00Cash sources and uses: $526,228,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $288,266,000.00Beginning cash$288.27 MEnding cash: Cash, cash equivalents, and restricted cash: $163,970,000.00Ending cash$163.97 MExchange-rate effect: -$2,327,000.00FX effect−$2.33 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$207.94 MOperating cash − cash spent on PP&ECash flow / Net income0.98×Operating cash flow ÷ net incomeNet cash change−$124.30 MEnding cash − beginning cash
Chart details

IDEXX LABORATORIES INC /DE cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025

Cash flows for Jan 1, 2025 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2024
288,266,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
237,962,000 US dollars. Net cash provided.
Net income
242,677,000 US dollars
Depreciation and amortization
34,063,000 US dollars
Provision for credit losses
2,890,000 US dollars
Deferred income taxes
3,948,000 US dollars
Share-based compensation expense
14,615,000 US dollars
Other
456,000 US dollars
Accounts receivable
negative 45,240,000 US dollars
Inventories
2,163,000 US dollars
Accounts payable
negative 8,123,000 US dollars
Deferred revenue
838,000 US dollars
Other assets and liabilities
negative 10,325,000 US dollars
Impairment charge
0 US dollars
Investing activities
negative 29,610,000 US dollars. Net cash used.
Purchases of property and equipment
negative 30,026,000 US dollars
Acquisition of a business
0 US dollars
Proceeds from net investment hedges
416,000 US dollars
Financing activities
negative 330,321,000 US dollars. Net cash used.
Shares withheld for statutory tax withholding payments on restricted stock
negative 6,124,000 US dollars
Borrowings under credit facility, net
69,500,000 US dollars
Proceeds from exercises of stock options and employee stock purchase plans
7,193,000 US dollars
Repurchases of common stock
negative 400,890,000 US dollars
Operating adjustment reconciliation
63,688,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
407,014,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
30,026,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 2,327,000 US dollars
Ending cash on Mar 31, 2025
163,970,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
526,228,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 124,296,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.98×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
237,962,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
30,026,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
207,936,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $237.96M of net income directly to operating cash and $4.72M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 237,962,000 US dollars minus 30,026,000 US dollars equals 207,936,000 US dollars.
IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!